Extraocular retinoblastoma: literature review and clinical case (intracranial retinoblastoma involving the visual tracts)

Author:

Ushakova T. L.1ORCID,Polyakov V. G.2ORCID,Rodina A. D.3ORCID,Vlasova V. E.4ORCID,Blankova T. I.4ORCID,Artemenko Yu. V.3ORCID,Mikhailova E. V.3ORCID,Krylov A. S.3ORCID,Odzharova A. A.3ORCID,Grigorenko V. A.3ORCID,Shirikov E. I.3ORCID,Kozlov N. A.3ORCID,Gasparyan T. G.5ORCID,Bekyashev A. Kh.3,Dokuchaeva Ya. Yu.3ORCID,Varfolomeeva S. R.1ORCID

Affiliation:

1. N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia; Russian Medical Academy of Continuous Professional Education, Ministry of Health of Russia

2. N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia; Russian Medical Academy of Continuous Professional Education, Ministry of Health of Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

3. N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia

4. N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

5. N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia; Scientific Center of Neurology, Ministry of Education and Science of Russia

Abstract

Relevance. Retinoblastoma (RB) is the most common primary intraocular tumor in children. The incidence of RB ranges from 1:14,000 to 1:20,000 newborns. To date, the survival rates of patients with RB reach almost 100 % with timely and adequate diagnosis. Among childhood oncological diseases, RB accounts for 2.3–4.5 % and 85–90 % among intraocular tumors in children. According to the volume of tumor spread, intra- and extraocular forms of the disease are distinguished. Extraocular RB is the spread of the tumor beyond the eye with invasion of the orbital tissues, as well as the possible involvement of adjacent areas, including intracranial without and with regional and/or remote metastases. The main method of treatment of children with extraocular RB is neoadjuvant chemotherapy (CT) with planning of surgical intervention and adjuvant therapy. High-dose CT (HDCT) with autologous hematopoietic stem cell transplantation (auto-HSCT), it allows to increase relapse-free survival in patients without metastatic lesions of the brain and spinal cord, but with their defeat, the prognosis of survival is extremely unfavorable, the nature of the disease is recurrent with 100 % lethality.Description of the clinical case. We report a case of bilateral RB: OD – with extraocular and intracranial spread of the tumor along the optic nerve with a lesion of the chiasm and a transition to the initial parts of the visual tracts. Secondary glaucoma. OS – with intraocular tumor growth in a 3-year-old child. After neoadjuvant chemotherapy, including intrathecal, a simultaneous two-stage operation was performed in the volume of bone-plastic (temporo-orbito-zygomatic) pterionic craniotomy on the right with prechiasmal resection of the right optic nerve and enucleation of the right eye. In the postoperative period, adjuvant chemotherapy was performed, followed by HDCT with auto-HSCT. Radiation therapy has become the final stage of treatment. Brachytherapy for OS tumor and remote radiotherapy for craniospinal region, right orbit, optic nerve stump with chiasm and pituitary pedicle were successively performed. After 14 months from the beginning of treatment and 5 months after its completion, a leptomeningeal relapse of the disease was detected.Conclusion. Rare observations of RB with damage to the visual tracts do not allow us to sufficiently study the features of the course of the tumor process, as well as to develop a single effective approach to antitumor treatment. Among the causes of mortality in patients with extraocular RB, the main one is metastasis, metastasis in the brain and spinal cord.

Publisher

OOO Grafika

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference21 articles.

1. Ishaq H., Patel B.C. Retinoblastoma. [Updated 2021 Nov 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK545276/.

2. Fabian I.D., Stacey A.W., Foster A., Kivelä T.T., Munier F.L., Keren-Froim N., Gomel N., Cassoux N., Sagoo M.S., Reddy M.A., Harby L.A., Zondervan M., Bascaran C., Abdallah E., Abdullahi S.U., Boubacar S.A., Ademola-Popoola D.S., Adio A., Aghaji A.E., Portabella S.A., Bio A.I.A., Ali A.M., Alia D.B., All-Eriksson C., Almeida A.A., Alsawidi K.M., Antonino R., Astbury N.J., Atsiaya R., Balaguer J., Balwierz W., Barranco H., Popovic M.B., Benmiloud S., Guebessi N.B., Berete R.C., Biddulph S.J., Biewald E.M., Blum S., Bobrova N., Boehme M., Bornfeld N., Bouda G.C., Bouguila H., Boumedane A., Brichard B.G., Capra M.L., Castela G., Català-Mora J., Chantada G.L., Chernodrinska V.S., Chiwanga F.S., Cieslik K., Comsa C., Llano M.G.C., Csóka M., Da Gama I.V., Davidson A., De Potter P., Desjardins L., Dragomir M.D., Du Bruyn M., Kettani A.E., Elbahi A.M., Elgalaly D., Elhaddad A.M., Elhassan M.M.A., Elzembely M.M., Essuman V.A., Evina T.G.A., Fasina O., Fernández-Teijeiro A., Gandiwa M., Aldana D.G., Geel J.A., Gizachew Z., Gregersen P.A., Guedenon K.M., Hadjistilianou T., Hassan S., Hederova S., Hessissen L., Hordofa D.F., Hummlen M., Husakova K., Ida R., Ilic V.R., Jenkinson H., Kabesha T.B.A., Kabore R.L., Kalinaki A., Kapelushnik N., Kardava T., Kemilev P.K., Kepak T., Khotenashvili Z., Klett A., Palet J.E.K.K., Krivaitiene D., Kruger M., Kyara A., Lachmann E.S., Latinović S., Lecuona K., Lukamba R.M., Lumbroso L., Lysytsia L., Maka E., Makan M., Manda C., Begue N.M., Matende I.O., Matua M., Mayet I., Mbumba F.B., Mengesha A.A., Midena E., Mndeme F.G., Mohamedani A.A., Moll A.C., Moreira C., Msina M.S., Msukwa G., Muma K.I., Murgoi G., Musa K.O., Mustak H., Muyen O.M., Naidu G., Naumenko L., Roth P.A.N., Neroev V., Nikitovic M., Nkanga E.D., Nkumbe H., Nyaywa M., Obono-Obiang G., Oguego N.C., Olechowski A., Oscar A.H., Osei-Bonsu P., Painter S.L., Paintsil V., Paiva L., Papyan R., Parrozzani R., Parulekar M., Pawinska-Wasikowska K., Perić S., Philbert R., Pochop P., Polyakov V.G., Pompe M.T., Pons J.J., Raobela L., Renner L.A., Reynders D., Ribadu D., Riheia M.M., Ritter-Sovinz P., Saakyan S., Said A.M., Pacheco S.S.R., Scanlan T.A., Schoeman J., Seregard S., Sherief S.T., Cheikh S.S., Silva S., Sorochynska T., Ssali G., Stathopoulos C., Kranjc B.S., Stones D.K., Svojgr K., Sylla F., Tamamyan G., Tandili A., Tateshi B., Theophile T., Traoré F., Tyau-Tyau H., Umar A.B., Urbak S.F., Ushakova T.L., Valeina S., van Hoefen Wijsard M., Veleva-Krasteva N.V., Viksnins M., Wackernagel W., Waddell K., Wade P.D., Nigeria A.H.W., Wime A.D., Dod C.W., Yanga J.M., Yarovaya V.A., Yarovoy A.A., Zein E., Sharabi S., Zhilyaeva K., Ziko O.A., Bowman R. Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries. Br J Ophthalmol. 2021;105(10):1435–43. doi: 10.1136/bjophthalmol-2020-316613.

3. Ancona-Lezama D., Dalvin L.A., Shields C.L. Modern treatment of retinoblastoma: A 2020 review. Indian J Ophthalmol. 2020;68(11):2356–65. doi: 10.4103/ijo.IJO_721_20.

4. Yanchenko T.V., Gromakina E.V. Epidemiological aspects of retinoblastoma. Meditsina v Kuzbasse. = Medicine in Kuzbass. 2015;14(2):4–9. (In Russ.).

5. Yanık Ö., Gündüz K., Yavuz K., Taçyıldız N., Ünal E. Chemotherapy in Retinoblastoma: Current Approaches. Turk J Ophthalmol. 2015;45(6):259–67. doi: 10.4274/tjo.06888.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3